Ad Code: 23168

Studies have shown that managing eczema in children has many challenges, including adherence to proven treatment regimens. Administering treatment can be time-consuming, the caregiver may have apprehensions regarding the use of...

For infants at high risk for atopic dermatitis (AD), early initiation of daily specialized emollient use until 2 months lessens the incidence of AD in the first year of life, according to a study published in Allergy. Jonathan...

Atopic eczema is associated with a small but increased risk for incident dementia, according to a study published in the Journal of the American Academy of Dermatology that assessed the association among nearly 1.8 million older...

For adult patients with atopic dermatitis (AD) who have not responded to systemic medications, abrocitinib, an oral Janus kinase (JAK) 1 inhibitor recently approved by the Food and Drug Administration (FDA), proved efficacious...